Literature DB >> 18321959

African sleeping sickness.

Francesco Checchi, Michael P Barrett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18321959      PMCID： PMC2276269          DOI： 10.1136/bmj.39505.490544.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

Review 1.  Human African trypanosomiasis.

Authors:  August Stich; Paulo M Abel; Sanjeev Krishna
Journal:  BMJ       Date:  2002-07-27

Review 2.  [Eflornithine in the treatment of African trypanosomiasis].

Authors:  F J Louis; J Keiser; P P Simarro; C Schmid; J Jannin
Journal:  Med Trop (Mars)       Date:  2003

3.  Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.

Authors:  François Chappuis; Nitya Udayraj; Kai Stietenroth; Ann Meussen; Patrick A Bovier
Journal:  Clin Infect Dis       Date:  2005-07-19       Impact factor: 9.079

Review 4.  Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).

Authors:  José A Castro; Maria Montalto de Mecca; Laura C Bartel
Journal:  Hum Exp Toxicol       Date:  2006-08       Impact factor: 2.903

5.  Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.

Authors:  Manica Balasegaram; Steve Harris; Francesco Checchi; Sara Ghorashian; Catherine Hamel; Unni Karunakara
Journal:  Bull World Health Organ       Date:  2006-10       Impact factor: 9.408

6.  A Trypanosoma brucei mutant resistant to alpha-difluoromethylornithine.

Authors:  M A Phillips; C C Wang
Journal:  Mol Biochem Parasitol       Date:  1987-01-02       Impact factor: 1.759

7.  Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo.

Authors:  Gerardo Priotto; Serena Kasparian; Daniel Ngouama; Sara Ghorashian; Ute Arnold; Salah Ghabri; Unni Karunakara
Journal:  Clin Infect Dis       Date:  2007-10-22       Impact factor: 9.079

Review 8.  Eflornithine for the treatment of human African trypanosomiasis.

Authors:  Christian Burri; Reto Brun
Journal:  Parasitol Res       Date:  2002-12-10       Impact factor: 2.289

9.  Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.

Authors:  Gerardo Priotto; Loretxu Pinoges; Isaac Badi Fursa; Barbara Burke; Nathalie Nicolay; Guillaume Grillet; Cathy Hewison; Manica Balasegaram
Journal:  BMJ       Date:  2008-03-05

10.  Nifurtimox plus Eflornithine for late-stage sleeping sickness in Uganda: a case series.

Authors:  Francesco Checchi; Patrice Piola; Harriet Ayikoru; Florence Thomas; Dominique Legros; Gerardo Priotto
Journal:  PLoS Negl Trop Dis       Date:  2007-11-07
View more
  4 in total

Review 1.  The paraflagellar rod of kinetoplastid parasites: from structure to components and function.

Authors:  Neil Portman; Keith Gull
Journal:  Int J Parasitol       Date:  2009-10-30       Impact factor: 3.981

2.  Digital gene expression analysis of two life cycle stages of the human-infective parasite, Trypanosoma brucei gambiense reveals differentially expressed clusters of co-regulated genes.

Authors:  Nicola J Veitch; Paul C D Johnson; Urmi Trivedi; Sandra Terry; David Wildridge; Annette MacLeod
Journal:  BMC Genomics       Date:  2010-02-22       Impact factor: 3.969

3.  Novel 4-substituted phenyl-2,2'-bichalcophenes and aza-analogs as antibacterial agents: a structural activity relationship.

Authors:  Warda A Hussin; Mohamed A Ismail; Wael M El-Sayed
Journal:  Drug Des Devel Ther       Date:  2013-03-22       Impact factor: 4.162

4.  Combining RNA interference mutants and comparative proteomics to identify protein components and dependences in a eukaryotic flagellum.

Authors:  Neil Portman; Sylvain Lacomble; Benjamin Thomas; Paul G McKean; Keith Gull
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.